Former FDA leader joins medical device security startup

Seth Carmody, PhD, formerly a cybersecurity program manager in the FDA’s Center for Devices and Radiological Health, has joined MedCrypt as vice president of regulatory strategy, the cybersecurity startup announced March 4.

Advertisement

Dr. Carmody served at the FDA for more than eight years. He held the cybersecurity program manager role, located in the office of the center’s director for emergency preparedness/operations and medical countermeasures, from early 2016 to February of this year.

In his new role, Dr. Carmody will build relationships with new and existing clients at MedCrypt, which provides medical devicemakers and healthcare technology companies with data encryption services.

“I’ve always wanted to work at a startup and build technology that solves problems on an economic scale. MedCrypt is making cybersecurity a turnkey feature for innovators developing new healthcare technology, rather than relying on policy alone to require this of all parties, from vendors to hospitals,” Dr. Carmody said in the announcement.

More articles on cybersecurity:
State-by-state breakdown of ransomware attacks on healthcare providers
5 recent data breaches caused by human error
Indiana hospital alerts 2,600 patients of human error data breach

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Designing the intelligent hospital: Building hospitals around people, data and care

Tuesday, July 21
12:00 PM - 1:00 PM CDT

Presenters: Braheem Santos, Schneider ElectricJohn Donohue, Penn Medicine

Advertisement

Next Up in Cybersecurity

Advertisement

Comments are closed.